PTGS2 and influenza: Our results suggest that inhibition of the antiviral factor COX-2 by anti-inflammatory drugs, such as the COX-2-specific inhibitor CAY10404 that was used in our study, may have detrimental outcome for treatment during an influenza disease because of a likely enhancement of viral replication.